Skip to main content
Year archive

ALLERGY THERAPEUTICS PLC — 2018 filings

All 32 regulatory filings released by ALLERGY THERAPEUTICS PLC (AGY) in 2018, sourced directly from the official regulator.

32 Filings
2018 Period
2018 filings (32)
Filing Released Lang
Holdings in Company
Major Shareholding Notification
2018-11-29 English
Result of AGM
AGM Information
2018-11-27 English
AGM Trading Update
Regulatory Filings
2018-11-27 English
Presentation at Jefferies Healthcare Conference
Report Publication Announcement
2018-11-12 English
Directorate Change
Board/Management Information
2018-11-08 English
Holdings in Company
Major Shareholding Notification
2018-11-07 English
Grant of Awards under Long Term Incentive Plan
Remuneration Information
2018-11-02 English
Holdings in Company
Major Shareholding Notification
2018-10-24 English
Director/PDMR Shareholding
Director's Dealing
2018-10-24 English
Annual Report and Accounts
Report Publication Announcement
2018-10-23 English
Holdings in Company
Major Shareholding Notification
2018-10-23 English
Preliminary Results
Earnings Release FY 2018
2018-09-26 English
Holding(s) in Company
Major Shareholding Notification
2018-07-27 English
Holding(s) in Company
Major Shareholding Notification
2018-07-26 English
Results of Placing and Subscription
Major Shareholding Notification
2018-07-19 English
Proposed placing & subscription to raise £10.6m
Capital/Financing Update
2018-07-19 English
BLOCK LISTING SIX MONTHLY RETURN
Remuneration Information
2018-07-16 English
Hardman & Co Research: Allergy Therapeutics (AGY): Steady performance in a tough market
Regulatory Filings
2018-07-13 English
Trading Update
Regulatory Filings
2018-07-12 English
Positive data with house-dust mite immunotherapy
Regulatory Filings
2018-05-29 English
Positive top-line results from Grass Ph II study
Regulatory Filings
2018-05-21 English
Publication of MCT Adjuvant Data
Regulatory Filings
2018-05-14 English
Grant of Awards under Long Term Incentive Plan
Director's Dealing
2018-03-16 English
Director/PDMR Shareholding
Director's Dealing
2018-03-16 English
Hardman: Clinical development towards submission
Regulatory Filings
2018-03-07 English
Interim Results
Interim / Quarterly Report H1 2018
2018-03-07 English
Polyvac® Peanut CMO appointed
Regulatory Filings
2018-02-28 English
Completion of recruitment in PQ Grass Ph II trial
Regulatory Filings
2018-02-12 English
Hardman Research: Growth in a tough market
Report Publication Announcement
2018-02-02 English
Trading Update
Earnings Release H1 2017
2018-01-31 English
Holdings in Company
Major Shareholding Notification
2018-01-10 English
PQ Birch Phase III trial completes recruitment
Regulatory Filings
2018-01-09 English